Objectives In patients with advanced liver disease, portal hypertension is an important risk
factor, leading to complications such as esophageal variceal bleeding, ascites, and hepatic …

Background There is a need for noninvasive methods for the diagnosis and monitoring of
portal hypertension (PH). Purpose To 1) assess the correlation of liver and spleen T1 and …

Background & Aims Hepatic venous pressure gradient (HVPG) measurement is currently the
only validated technique to accurately evaluate changes in portal pressure. In this study, we …

Background and aims Non-invasive assessment of portal hypertension is an area of unmet
need. This proof of concept study aimed to evaluate the diagnostic accuracy of a multi …

Purpose To assess the diagnostic value of a fast scoring system based on non-invasive
cross-sectional imaging to predict portal hypertension (PH) in patients with liver disease …

Purpose To analyze the predictive value of ΔT1 of the liver and spleen as well as the
extracellular volume fraction (ECV) of the spleen as noninvasive biomarkers for the …

Purpose To investigate the feasibility of estimating the portal vein blood volume that flows
into the intrahepatic volume (IHPVBV) in each cardiac cycle using non-contrast MR …

Background Currently, the hepatic venous pressure gradient (HVPG) remains the reference
standard for diagnosis of clinically significant portal hypertension (CSPH) but is limited by its …

Portal hypertension (PH) is a spectrum of complications of chronic liver disease (CLD) and
cirrhosis, with manifestations including ascites, gastroesophageal varices, splenomegaly …

Aims Hepatic venous pressure gradient (HVPG) is critical for staging and prognosis
prediction of portal hypertension (PH). However, HVPG measurement has limitations (eg …